| BEYOND AIR INC. O.N. |
| USA |
| Gesundheit |
| US08862L2025 / A41C99 |
| 48L0 (Frankfurt) / XAIR (NASDAQ) |
| FRA:48L0, ETR:48L0, 48L0:GR, NASDAQ:XAIR |
| - |
| https://www.beyondair.net.. |
|
Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company specializing in nitric oxide therapy. Central to its offerings is the LungFit platform, an innovative nitric oxide generator and delivery system that uses patented Ioni..
>Volltext.. |
| 6.47 Mio. EUR |
| 11.6 Mio. EUR |
| 6 Mio. EUR |
| -21.98 Mio. EUR |
| -26.86 Mio. EUR |
| -4.7 EUR |
| 20.44 Mio. EUR |
| 11.11 Mio. EUR |
| -17.46 Mio. EUR |
| 3.58 |
| 129.04% |
| 40.72% |
| - |
| - |
| - |
| - |
| BEYOND AIR |
| 05.04.26 |
|